Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02790853 · ClinicalTrials.gov registry record · Early Phase 1
Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders
A Early Phase 1 study of Dysplasia and Premalignant Lesion, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Early Phase 1
- Development phase
- 63
- Enrollment target
- 1
- Study location
NCT02790853 is a Early Phase 1 study of Dysplasia and Premalignant Lesion that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 63 participants, below the 843-participant average among 4 other Dysplasia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02790853, a Early Phase 1 study of Dysplasia and Premalignant Lesion, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 63 participants
- Enrollment target
- 1
- Study location
Study Summary
This early phase I trial studies how well multimodal imaging works for surveillance in patients with oral potentially malignant disorders. New types of imaging devices may help doctors decide if a lesion in the mouth is pre-cancerous or cancerous.
Conditions Studied
Interventions
- PROCEDURE Biopsy
- PROCEDURE High-Resolution Microendoscopy
- DRUG Proflavine Hemisulfate
- PROCEDURE Fluorescence Imaging
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2016-05-25 |
| Est. Completion | 2026-05-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02790853
The ClinicalTrials.gov registry entry for NCT02790853 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 843-participant average among 4 other Dysplasia trials with a reported enrollment target (93% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Dysplasia appearing as the primary indexed condition, and to 4 interventions - of which Biopsy is the first listed.
NCT02790853 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02790853 about?
NCT02790853 is a clinical study titled "Multimodal Imaging for Surveillance in Patients With Oral Potentially Malignant Disorders". This early phase I trial studies how well multimodal imaging works for surveillance in patients with oral potentially malignant disorders. New types of imaging devices may help doctors decide if a lesion in the mouth is pre-cancerous or cancerous.
What is the current status of trial NCT02790853?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 63 participants. The study started on 2016-05-25. Estimated completion is 2026-05-31.
What conditions does trial NCT02790853 study?
This clinical trial studies the following conditions: Dysplasia, Premalignant Lesion, Lip and Oral Cavity Carcinoma, Oral Disorder.
What interventions are being tested in trial NCT02790853?
The interventions under investigation include: Biopsy (PROCEDURE), High-Resolution Microendoscopy (PROCEDURE), Proflavine Hemisulfate (DRUG), Fluorescence Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT02790853?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02790853 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Collecting Health Information to Understand and Prevent Gastric Cancer
RECRUITING
-
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
COMPLETED
-
Esophageal Cytology With FISH in Detecting Esophageal Cancer
COMPLETED · NA
-
Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.